GAO Says Strategic Sourcing Benefits Realized, Wants Expansion
Client Alert | less than 1 min read | 11.18.16
Last month, GAO issued a report on strategic sourcing that addresses how successful the Federal Strategic Sourcing Initiative (FSSI) program has been to date. While the report found that, from FY2011-15, agencies reported spending almost $2 billion through the FSSI and claimed $470 million in savings, the report also found that “agencies’ low use of the FSSIs … diminished the potential savings that could have been achieved” – an underutilization that GAO attributed partially to the Strategic Sourcing Leadership Council agencies directing only “10 percent of their collective spending to the FSSIs[,]” with GAO calling for more aggressive targets to be set.
Contacts
Insights
Client Alert | 3 min read | 01.21.26
Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement
On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion.
Client Alert | 3 min read | 01.21.26
FedRAMP Proposes Updates to Authorization Process—Six New RFCs Released for Public Comment
Client Alert | 3 min read | 01.20.26
DoW Joins SBA’s Fight Against Alleged Pass-Through Fraud in the 8(a) Program
Client Alert | 3 min read | 01.20.26
Federal Government Challenges Minnesota Law Requiring Affirmative Action in State Government
